126 related articles for article (PubMed ID: 1021234)
1. Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
Drewinko B; Green C; Loo TL
Cancer Treat Rep; 1976 Nov; 60(11):1619-25. PubMed ID: 1021234
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells.
Drewinko B; Loo TL; Brown B; Gottlieb JA; Freireich EJ
Cancer Biochem Biophys; 1976 May; 1(4):187-95. PubMed ID: 975020
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
Bergerat JP; Green C; Drewinko B
Cancer Biochem Biophys; 1979; 3(4):173-80. PubMed ID: 575983
[TBL] [Abstract][Full Text] [Related]
4. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
[TBL] [Abstract][Full Text] [Related]
5. Cellular response to treatment with 4-(3-(2-chloroethyl)-3-nitrosoureido)-cis-cyclohexanecarboxylic acid, a water-soluble nitrosourea derivative.
Drewinko B; Green C; Loo TL
Cancer Treat Rep; 1977 Nov; 61(8):1513-8. PubMed ID: 922754
[TBL] [Abstract][Full Text] [Related]
6. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.
Melvik JE; Pettersen EO
Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438
[TBL] [Abstract][Full Text] [Related]
7. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
8. Cytostatic activity in vitro of new cis-dichlorodiammineplatinum (II) analogs.
Duś D; Kuduk-Jaworska J
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):357-61. PubMed ID: 6892202
[TBL] [Abstract][Full Text] [Related]
9. Combination effects of cis-dichlorodiammineplatinum with selected metahalones, pyrimidine sulfoxides and pyrimidine sulfones on human NHIK 3025 cells in vitro.
Dornish JM; Undheim K; Pettersen EO; Oftebro R; Laland SG
Anticancer Drug Des; 1988 Dec; 3(3):191-8. PubMed ID: 3207466
[TBL] [Abstract][Full Text] [Related]
10. Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.
Bergerat JP; Barlogie B; Drewinko B
Cancer Res; 1979 Apr; 39(4):1334-8. PubMed ID: 421217
[TBL] [Abstract][Full Text] [Related]
11. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
Melvik JE; Dornish JM; Larsen RO; Børretzen B; Oftebro R; Pettersen EO
Anticancer Res; 1992; 12(1):33-8. PubMed ID: 1567178
[TBL] [Abstract][Full Text] [Related]
12. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Aida T; Bodell WJ
No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
[TBL] [Abstract][Full Text] [Related]
13. Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar.
Wu PC; Ozols RF; Hatanaka M; Boone CW
J Natl Cancer Inst; 1982 Jan; 68(1):115-21. PubMed ID: 6948121
[TBL] [Abstract][Full Text] [Related]
14. Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Aida T; Bodell WJ
Cancer Res; 1987 Mar; 47(5):1361-6. PubMed ID: 3469016
[TBL] [Abstract][Full Text] [Related]
15. Cycle-dependent anticancer drug cytotoxicity in mammalian cells synchronized by centrifugal elutriation.
Meyn RE; Meistrich ML; White RA
J Natl Cancer Inst; 1980 May; 64(5):1215-9. PubMed ID: 6154171
[TBL] [Abstract][Full Text] [Related]
16. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
Ujiie T
Jpn J Exp Med; 1988 Feb; 58(1):33-8. PubMed ID: 2454340
[TBL] [Abstract][Full Text] [Related]
18. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced DNA damage and lethality in E. coli as modified by the antitumor agent cis-dichlorodiammineplatinum (II).
Richmond RC; Zimbrick JD; Hykes DL
Radiat Res; 1977 Aug; 71(2):447-60. PubMed ID: 331388
[No Abstract] [Full Text] [Related]
20. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
